Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Net Income (2017 - 2026)

Integra Lifesciences Holdings' Net Income history spans 16 years, with the latest figure at -$1.7 million for Q4 2025.

  • On a quarterly basis, Net Income fell 108.77% to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$516.5 million, a 7338.77% decrease, with the full-year FY2025 number at -$516.5 million, down 7337.7% from a year prior.
  • Net Income hit -$1.7 million in Q4 2025 for Integra Lifesciences Holdings, up from -$5.4 million in the prior quarter.
  • Over the last five years, Net Income for IART hit a ceiling of $52.9 million in Q4 2022 and a floor of -$484.1 million in Q2 2025.
  • Historically, Net Income has averaged -$5.3 million across 5 years, with a median of $19.7 million in 2023.
  • Biggest five-year swings in Net Income: surged 9603.52% in 2021 and later tumbled 3803.18% in 2025.
  • Tracing IART's Net Income over 5 years: stood at $45.4 million in 2021, then rose by 16.66% to $52.9 million in 2022, then crashed by 62.54% to $19.8 million in 2023, then fell by 2.01% to $19.4 million in 2024, then plummeted by 108.77% to -$1.7 million in 2025.
  • Business Quant data shows Net Income for IART at -$1.7 million in Q4 2025, -$5.4 million in Q3 2025, and -$484.1 million in Q2 2025.